In aesthetic and dermatological procedures, post-treatment care determines recovery speed, comfort, and final results. LUMIDOR After Care Cream, manufactured by ABio Materials Co. in pharmaceutical-grade facilities in Korea, delivers exosome-powered care designed for delicate, damaged, or post-treated skin through adipose-derived stem cell culture extract, Exo-Cica®, Centella Asiatica Extract, Madecassoside, and Tranexamic Acid. This US FDA-listed treatment provides post-treatment recovery support, firming and revitalization, brightening assistance, and barrier repair for sensitive or compromised skin types. This page explores the scientific mechanisms, clinical applications, and evidence-based benefits of LUMIDOR After Care Cream.
Procedures that improve skin whether professional treatments or aggressive at-home care temporarily compromise barriers and trigger inflammation, requiring strategic support for optimal healing.
The formulation contains conditioned media from adipose-derived stem cells, rich in growth factors, cytokines, and signaling molecules that accelerate tissue repair, stimulate collagen synthesis, reduce inflammation, and promote cellular regeneration. These bioactive compounds communicate directly with compromised skin cells to activate healing pathways and restore normal function following trauma.
The cream incorporates three forms of Centella Asiatica benefits: Exo-Cica® exosomes for deep delivery of anti-inflammatory compounds, Centella Asiatica Extract providing traditional soothing and wound healing support, and Madecassoside, a purified active compound with potent anti-inflammatory and barrier-repairing properties. This triple approach delivers comprehensive calming and healing through complementary mechanisms.
Post-inflammatory hyperpigmentation frequently follows procedures or trauma. Tranexamic Acid inhibits melanin synthesis through multiple pathways, preventing dark spots from forming during the healing process. This proactive approach addresses discoloration before it becomes established, supporting even-toned recovery.
Beyond active healing compounds, the formulation delivers barrier-supporting lipids and protective ingredients that reinforce compromised stratum corneum, prevent infection, and maintain optimal moisture levels during vulnerable recovery periods.
Adipose-derived stem cell extract accelerates healing after dermatological procedures through growth factor support and tissue repair activation.
Stem cell bioactives boost elasticity and skin density, counteracting the temporary laxity that can follow aggressive treatments.
Tranexamic Acid helps fade discoloration and prevent post-inflammatory hyperpigmentation during healing, supporting even-toned recovery.
Comprehensive lipid delivery and Centella compounds strengthen compromised skin, reducing permeability and increasing resilience.
Triple Centella complex (Exo-Cica®, Extract, and Madecassoside) provides intensive anti-inflammatory support through complementary pathways.
Formulated specifically for sensitive or compromised skin types, avoiding irritants that could impede healing.
LUMIDOR After Care Cream provides essential support for skin recovering from procedures or experiencing compromise requiring intensive care.
Post-procedure recovery following chemical peels, laser treatments, microneedling, or radiofrequency providing comprehensive healing support
Sensitive or compromised skin types experiencing chronic sensitivity or barrier dysfunction requiring intensive repair
Brightening-focused users addressing post-inflammatory hyperpigmentation or uneven tone following trauma or inflammation
Professional aftercare, as recommended follow-up treatment prescribed by dermatologists or aestheticians following in-office procedures
Environmental damage recovery supporting skin healing from severe sun exposure, wind damage, or other environmental trauma
Aggressive treatment tolerance allowing continued use of beneficial but potentially irritating treatments through enhanced barrier support
Beginning immediately after procedure (or as directed by provider), apply a generous amount to treated areas 2-3 times daily. Continue intensive application for the first 3-7 days, depending on procedure intensity and recovery progress.
For chronic sensitivity or barrier compromise, apply twice daily as the final skincare step, focusing additional product on particularly compromised areas.
Can be applied to specific areas experiencing sensitivity, discoloration, or compromise while using standard moisturizer elsewhere.
Always follow morning application with broad-spectrum sunscreen, particularly critical during post-procedure healing when photosensitivity increases.
Pat or press gently onto skin rather than rubbing, which could irritate compromised tissue. Allow full absorption before applying additional products.
LUMIDOR After Care Cream represents pharmaceutical-grade post-treatment formulation development. Stem cell extract is verified for growth factor content, Centella compounds are standardized for consistent potency, Tranexamic Acid concentration is optimized for efficacy without irritation, and the complete formulation excludes common sensitizers that could impede healing.
Manufacturing occurs in Korean facilities certified to ISO 13485 and GMP standards. Each batch undergoes testing: stem cell extract bioactivity verification, Centella compound potency confirmation, Tranexamic Acid concentration validation, microbiological safety per USP protocols, pH verification ensuring compatibility with compromised barriers, and stability confirmation under various conditions.
This pharmaceutical approach ensures the cream provides safe, effective support for vulnerable post-procedure or compromised skin, distinguishing LUMIDOR from conventional after-care products developed without comparable scientific rigor.
LUMIDOR After Care Cream contains Adipose-Derived Stem Cell Culture Extract, Exo-Cica®, Centella Asiatica Extract, Madecassoside, and Tranexamic Acid, developed for post-treatment recovery and barrier repair. Full technical data is available upon request.
Yes. LUMIDOR After Care Cream is available for personal skincare use. It can be purchased through ABio Materials USA Inc., the exclusive North American distributor.
Apply generously to treated or compromised areas 2-3 times daily during intensive recovery periods, or twice daily for ongoing sensitive skin support. Pat gently onto skin. Always follow with sunscreen during the day.
All ABio Materials products are US FDA-listed and produced in pharmaceutical-grade facilities in Korea in accordance with applicable manufacturing standards. The product is not intended to diagnose, treat, or cure any medical condition.
All production is conducted by ABio Materials Co. in pharmaceutical-grade facilities in Korea under strict U.S. quality assurance and regulatory compliance protocols.
Individuals may contact ABio Materials USA Inc., the exclusive North American distributor, via a-biousa.com to request information about product availability or purchasing options.
LUMIDOR After Care Cream represents the advancement of post-procedure care through stem cell biotechnology and comprehensive barrier support. By combining growth factor delivery with intensive calming and brightening, ABio Materials Co. delivers professional-grade recovery support for home use.
To learn more about LUMIDOR After Care Cream or explore the complete LUMIDOR product line, visit a-biousa.com.
We welcome inquiries from partners, distributors, and industry professionals worldwide. Whether you are interested in our product portfolio, ODM/OEM collaboration, or research support, our team is committed to providing clear, timely, and knowledgeable assistance. Reach out to learn how our bio-material technologies and exosome expertise can support your clinical, aesthetic, or research goals.
